1202528-03-7

Upstream product

• 95-78-3 2,5-Dimethylaniline 
• 2050-44-4 N-(2,5-dimethylphenyl)acetamide 
• 885223-72-3 5-bromo-6-methyl-1H-indazole 
• 352-34-1 4-fluoro-1-iodobenzene 
• 13711-31-4 N-(4-bromo-2,5-dimethyl-phenyl)acetamide 
• 1202527-94-3 1-acetyl-5-bromo-6-methyl-1H-indazole 
• 1765-93-1 4-fluoroboronic acid 

Downstream Products

• 1025763-15-8 methyl 1-(4-fluorophenyl)-6-methyl-1H-indazole-5-carboxylate 
• 1616361-43-3 rac-4-(1-(4-fluorophenyl)-6-methyl-1H-indazol-5-yl)-1-methyl-3-(pyridin-2-yl)-6,8-dihydro-1H-pyrazolo[3,4-e][1,4]thiazepin-7(4H)-one 
• 1616364-11-4 1-(4-fluorophenyl)-6-methyl-1H-indazole-5-carbaldehyde 
• 1025763-16-9 (1-(4-fluorophenyl)-6-methyl-1H-indazol-5-yl)methanol 

Relevant academic research and scientific papers

HETEROCYCLIC NUCLEAR HORMONE RECEPTOR MODULATORS

The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.

TETRACYCLIC COMPOUND

Provided are a tetracyclic compound represented by the formula (I): [in the formula(I),the formula (A) represents a benzene ring or the like, X represents CH or a nitrogen atom, Q represents -O- or the like, R1, R2, and R3 may be the same or different and each represent a hydrogen atom or the like, 1, m, and n each represent an integer from one to the maximum substitutable number of substituents, and R4 and R5 may be the same or different and each represent a hydrogen atom or the like], or a pharmaceutically acceptable salt thereof, and the like.